Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Tax Provisions (2016 - 2026)

Champions Oncology has reported Tax Provisions over the past 16 years, most recently at $42000.0 for Q1 2026.

  • Quarterly results put Tax Provisions at $42000.0 for Q1 2026, up 82.61% from a year ago — trailing twelve months through Jan 2026 was -$55000.0 (down 111.54% YoY), and the annual figure for FY2025 was -$75000.0, down 134.38%.
  • Tax Provisions for Q1 2026 was $42000.0 at Champions Oncology, up from $18000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for CSBR hit a ceiling of $42000.0 in Q1 2026 and a floor of -$129000.0 in Q2 2025.
  • Median Tax Provisions over the past 5 years was $14000.0 (2022), compared with a mean of $2705.9.
  • Biggest five-year swings in Tax Provisions: surged 1100.0% in 2023 and later plummeted 505.0% in 2024.
  • Champions Oncology's Tax Provisions stood at $14000.0 in 2022, then decreased by 21.43% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then soared by 63.64% to $18000.0 in 2025, then surged by 133.33% to $42000.0 in 2026.
  • The last three reported values for Tax Provisions were $42000.0 (Q1 2026), $18000.0 (Q4 2025), and $14000.0 (Q3 2025) per Business Quant data.